Belite Bio (BLTE) Cash from Investing Activities (2020 - 2025)
Belite Bio (BLTE) posted quarterly Cash from Investing Activities of -$303.7 million for Q4 2025, down 1067.58% year-over-year from $31.4 million in Q4 2024, and down 1067.58% quarter-over-quarter from -$26.0 million in Q4 2024.
Powered by 
Analysis
Belite Bio (BLTE) Cash from Investing Activities (2020 - 2025) Analysis & Trends
Belite Bio's Cash from Investing Activities history runs 2 years deep, the most recent figure standing at -$303.7 million for Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 329.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -1.66 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -49.35 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -363.46 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -229.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Belite Bio | 6.44 Bn | 6.44 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -303.73 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Dec 31, 2022 | -394,000.00 |
| Dec 31, 2021 | -56,000.00 |
| Dec 31, 2020 | -20,000.00 |